-
Story /With extensive experience in public health management, having worked for the International Red Cross, among others, and as a doctor in emergency situations on the ground in Africa and Asia— Ann Aerts discusses the Novartis Foundation's new leprosy strategy.
-
Story /When Laurie Brunner found a lump in her breast just before Thanksgiving in 2018, it was the beginning of one of the most difficult periods of her life. Although treatment put her cancer into remission, she found herself dealing with an emotional toll that affects many survivors of early-stage breast cancer: the fear of it coming back.
Photos: Brent Stirton, Getty Images for Novartis
-
Press release /In Phase II studies, Zykadia (ceritinib) shrank tumors in patients with ALK+ NSCLC; comparable overall response in those with or without brain metastases[1],[2] Tafinlar (dabrafenib) and…
-
Story /Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.
-
Story /Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.
-
Story /Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.
-
Press release /CHMP positive opinion for EU approval of Tafinlar and Mekinist combination in BRAF V600 mutation-positive melanoma, the most aggressive type of skin cancer FDA grants priority review for…
-
Press release /COVID-19 pandemic triggered a massive surge in virtual health and care delivery across the world, with many countries embracing hybrid virtual and in-person services Report from the Broadband…
-
Story /A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
Pagination
- ‹ Previous page
- 1
- …
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- …
- 172
- › Next page